An anti-tumor traditional Chinese medicine, a preparation method therefor, and uses thereof. This traditional Chinese medicine is prepared by leavening of Pleurotus sp. and Dioscorea bulbifera, pangolin scales, rhubarb, oyster, stiff silkworm, kelp, selfheal, Ligusticum wallichii, barbat skullcap, honeysuckle flower, Oldenlandia diffusa, Radix trichosanthis, Rhizoma anemarrhenae Scutellaria baicalensis, Angelica sinensis, Psoralea corylifolia, Lucid ganoderma, and coix seed.

An anti-tumor traditional Chinese medicine, a preparation method therefor, and uses thereof. This traditional Chinese medicine is prepared by leavening of Pleurotus sp. and Dioscorea bulbifera, pangolin scales, rhubarb, oyster, stiff silkworm, kelp, selfheal, Ligusticum wallichii, barbat skullcap, honeysuckle flower, Oldenlandia diffusa, Radix trichosanthis, Rhizoma anemarrhenae Scutellaria baicalensis, Angelica sinensis, Psoralea corylifolia, Lucid ganoderma, and coix seed.

A multi time-phase treatment for one of a range of maladies. A dosage form is administered in a first dosage of a therapeutic effective amount of a first plant concentrate or one of its physiological acceptable forms. A dosage form is administered in a second dosage of a therapeutic effective amount of a second plant concentrate or one of its physiological acceptable forms. The first dosage is applied at a first time-phase and the second dosage is applied at a second time-phase spaced from the first time-phase. A combination of the first and second dosage forms administered in at least the first and second time-phases assist in treatment of abnormal cells for treatment for one of the range of maladies.

A multi time-phase treatment for one of a range of maladies. A dosage form is administered in a first dosage of a therapeutic effective amount of a first plant concentrate or one of its physiological acceptable forms. A dosage form is administered in a second dosage of a therapeutic effective amount of a second plant concentrate or one of its physiological acceptable forms. The first dosage is applied at a first time-phase and the second dosage is applied at a second time-phase spaced from the first time-phase. A combination of the first and second dosage forms administered in at least the first and second time-phases assist in treatment of abnormal cells for treatment for one of the range of maladies.

A multi time-phase treatment for one of a range of maladies. A dosage form is administered in a first dosage of a therapeutic effective amount of a first plant concentrate or one of its physiological acceptable forms. A dosage form is administered in a second dosage of a therapeutic effective amount of a second plant concentrate or one of its physiological acceptable forms. The first dosage is applied at a first time-phase and the second dosage is applied at a second time-phase spaced from the first time-phase. A combination of the first and second dosage forms administered in at least the first and second time-phases assist in treatment of abnormal cells for treatment for one of the range of maladies.

There is disclosed a clear skin supplement/medicinal component for acne comprising: an orally administered dosage comprising of between about 3000-9000 mg of the Chinese medicinal composition comprising by ratio: around 3.8-7.6% of each of Prunus persica, Carthamus tinctorius, Angelica dahurica, Gleditsia sinensis, Viola yedoensis, Paeonia suffruticosa and gardenia jasminoides; around 5.7-7.6% of each of Oldenlandia diffusa and Scutellaria baicalensis; around 3.8-5.7% of Salvia miltiorrhiza; around 2.5-5.7% of Phellodendron amurense; around 2.5-7.6% of Gentiana scabra; and around 0-7.6% of each of Taraxacum mongolicum and any one of Lonicera japonica/Rhizoma Coptidas/Sophora flavescens.

There is disclosed a clear skin supplement/medicinal component for acne comprising: an orally administered dosage comprising of between about 3000-9000 mg of the Chinese medicinal composition comprising by ratio: around 3.8-7.6% of each of Prunus persica, Carthamus tinctorius, Angelica dahurica, Gleditsia sinensis, Viola yedoensis, Paeonia suffruticosa and gardenia jasminoides; around 5.7-7.6% of each of Oldenlandia diffusa and Scutellaria baicalensis; around 3.8-5.7% of Salvia miltiorrhiza; around 2.5-5.7% of Phellodendron amurense; around 2.5-7.6% of Gentiana scabra; and around 0-7.6% of each of Taraxacum mongolicum and any one of Lonicera japonica/Rhizoma Coptidas/Sophora flavescens.

A medicament for use in treating cardiovascular and cerebrovascular diseases, the medicament includes a marine algal glycoprotein.

A medicament for use in treating cardiovascular and cerebrovascular diseases, the medicament includes a marine algal glycoprotein.

A medicament for use in treating cardiovascular and cerebrovascular diseases, the medicament includes a marine algal glycoprotein.